Independent Researcher, Adana, Turkey.
Department of Ophthalmology, World Eye Hospital, Adana, Turkey.
J Popul Ther Clin Pharmacol. 2020 May 1;27(2):e45-e50. doi: 10.15586/jptcp.v27i2.665.
Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric conditions in childhood. Psychopharmacological therapy is an effective treatment for ADHD. In this study, we primarily aim to investigate the effects of psychopharmacological agents on intraocular pressure (IOP) in children with ADHD. The sample included 82 children with ADHD and 36 healthy children aged between 8 and 12 years who were referred to the Department of Child and Adolescent Psychiatry in Hatay State Hospital, Hatay, Turkey. Children with ADHD were divided into two groups according to the medication used: methylphenidate (MPH) group and atomoxetine (ATX) group. Before treatment and after 1- and 6-month treatment period, IOP was measured by Goldmann applanation tonometry. There were no statistical differences in terms of age, gender, and IOP between the three groups (P > 0.05). After 1- and 6-month treatment, the IOP did not change significantly between baseline and 1 month or 6 months (P > 0.05). Children with ADHD may have an IOP similar to healthy children. Six-month treatment with MPH or ATX may not cause significant changes in IOP.
注意缺陷多动障碍(ADHD)是儿童期最常见的精神疾病之一。精神药理学治疗是 ADHD 的有效治疗方法。在这项研究中,我们主要旨在研究精神药理学药物对 ADHD 儿童眼内压(IOP)的影响。该样本包括 82 名 ADHD 儿童和 36 名年龄在 8 至 12 岁之间的健康儿童,他们被转介到土耳其哈塔伊州立医院的儿童和青少年精神病学系。根据使用的药物,将 ADHD 儿童分为两组:哌醋甲酯(MPH)组和阿托西汀(ATX)组。在治疗前和治疗 1 个月和 6 个月后,使用 Goldmann 压平眼压计测量 IOP。三组之间的年龄、性别和 IOP 无统计学差异(P>0.05)。治疗 1 个月和 6 个月后,与基线相比,IOP 在 1 个月或 6 个月时没有明显变化(P>0.05)。ADHD 儿童的 IOP 可能与健康儿童相似。使用 MPH 或 ATX 治疗 6 个月可能不会导致 IOP 显著变化。